NEW YORK , Oct. 24 – Affymetrix reported flat third-quarter revenues despite increasing sales of its GeneChip product increased, the company said on Wednesday. 

Affy's overall third-quarter revenues totaled $55.4 million, compared to $55.8 million for the same period one year ago. Product revenue increased to $47.3 million from $45.4 million for the year-ago quarter, the company said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.